GenVivo, Inc.   Report issue

For profit Phase 1
Founded: san marino ca United States (2019)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

GenVivo, Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

gen2 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 1)

Carcinoma, Hepatocellular (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1